Form 8-K - Current report:
SEC Accession No. 0001558370-24-013244
Filing Date
2024-10-10
Accepted
2024-10-10 16:42:37
Documents
16
Period of Report
2024-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20241008x8k.htm   iXBRL 8-K 40075
2 EX-10.1 pmn-20241008xex10d1.htm EX-10.1 54946
3 EX-10.2 pmn-20241008xex10d2.htm EX-10.2 107829
  Complete submission text file 0001558370-24-013244.txt   369210

Data Files

Seq Description Document Type Size
4 EX-101.SCH pmn-20241008.xsd EX-101.SCH 4050
5 EX-101.DEF pmn-20241008_def.xml EX-101.DEF 2874
6 EX-101.LAB pmn-20241008_lab.xml EX-101.LAB 17909
7 EX-101.PRE pmn-20241008_pre.xml EX-101.PRE 11840
18 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20241008x8k_htm.xml XML 5044
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 241365641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)